-
The FDA has approved a new drug for the treatment of gastrointestinal stromal tumor and metastatic renal cell cancer. Sunitinib is an orally active, highly selective, multi-targeted tyrosine kinase inhibitor. The drug was given a priority review and was approved in less than 6 months. Sunitinib is marketed by Pfizer as Sutent®.
-
Erectile Dysfunction and Subsequent Cardiovascular Disease; Oseltamivir Resistance during Influenza A Infection; Dietary Intake of Antioxidants and AMD
-
-
Observations with new drug-eluting stents have suggested that percutaneous coronary intervention (PCI) on left main coronary artery stenosis unprotected by a bypass graft may be safe and effective.
-
The new 64-slice cardiovascular computed tomography (CVCT) is theoretically superior to the old 16-slice CT for detecting coronary artery disease (CAD).
-
Several observational studies, as well as some animal research have suggested a beneficial role of statins in subjects with acute bacterial infection and sepsis. The hypothesis that statins may manifest non-lipid actions (pleiotropic effects) has been a popular theme for years.
-
Can Calcium and Vitamin D Prevent Hip Fractures?; Treatment of Benign Prostatic Hyperplasia; Treatment of Osteoarthritis of the Knee; Refractory Asthma and TNFConnection?; FDA Actions
-
-
Enhanced external counterpulsation (eecp) has been shown to be effective in reducing symptoms in patients with refractory angina and congestive heart failure, ...
-
Cinefluoroscopy (cf) has been the gold standard for the evaluation of suspected mechanical prosthetic valve thrombosis, but only provides an analysis of leaflet motion.
